Selkirk Management’s Cardlytics CDLX Stock Holding History

Selkirk Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,060	Closed	-$5.93M	–	16
2021 Q3	$5.93M	Hold	7,060	–	–	2.41%	13
2021 Q2	$8.96M	Buy	7,060 +650	+10%	+$734K	3.26%	13
2021 Q1	$7.03M	Buy	6,410 +3,910	+156%	+$5.16M	2.09%	17
2020 Q4	$3.57M	Hold	2,500	–	–	1.16%	17
2020 Q3	$1.76M	Hold	2,500	–	–	0.56%	21
2020 Q2	$1.75M	Buy	+2,500	New	+$1.44M	0.75%	21

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Selkirk Management's CDLX Position: Q4 2021 in Review

Selkirk Management sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 7,060 shares — an estimated $5.93M sold.

Selkirk Management first reported a position in CDLX in Q2 2020 and held it in 6 quarters. The position peaked at $8.96M in Q2 2021. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

Selkirk Management reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
Selkirk Management sold 7,060 Cardlytics shares in Q4 2021, an estimated $5.93M.
Selkirk Management first reported a position in Cardlytics in Q2 2020 and held it in 6 quarters.
Selkirk Management's Cardlytics position peaked at $8.96M in Q2 2021.
163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on Selkirk Management's 13F filing for Q4 2021, filed 14 Feb 2022.